JPRN-UMIN000024686已完成2 期
Induction chemotherapy with docetaxel, cisplatin and 5-fluorouracil followed by chemoradiotherapy concurrent with fractionated administration of high-dose cisplatin for patients with locally advanced squamous cell carcinoma of the head and neck - TPF study for Japanese
ational Cancer Center Hospital East0 个研究点目标入组 48 人开始时间: 2016年11月2日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Active bacterial or fungus infection Active Malignant disease, other than that being treated in this study Pregnant or lactating women Clinically significant and/or uncontrolled heart disease History of cerebrovascular disease Uncontrolled diabetes or hypertension Severe complications
研究者
相似试验
进行中（未招募）
不适用
Induction chemotherapy with docetaxel and cisplatin followed by radiotherapy concomitant with cetuximab for locally advanced stage III non-small cell lung cancer- amulticentre, open label non-randomised phase II trial - SatellitPatient with locally advanced stage III non-small cell lung cancer.EUCTR2005-003867-21-SESahlgrenska University Hospital75
进行中（未招募）
2 期
Induction chemotherapy for HPV positive oropharyngeal cancers (HIPPOCRATES)Human papillomavirus-associated oropharyngeal cancersHuman papillomavirus, oropharyngeal cancersJPRN-jRCT1041220029Yokota Tomoya30
未知
1 期
Combination chemotherapy with docetaxel, cisplatine, and 5-fluorouracil for patients with advanced head and neck cancer: a phase I/II trialSquamous cell carcinoma of the head and neckJPRN-UMIN000000744Department of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine, University of Yamanashi53
Unknown
3 期
Induction Chemotherapy of TPX in Nomogram-predicted High Risk Locoregionally Advanced Nasopharyngeal CarcinomaNasopharyngeal CarcinomaNCT02786641Sun Yat-sen University235
已完成
1 期
Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or HypopharynxHead and Neck CancerNCT00498953European Organisation for Research and Treatment of Cancer - EORTC7